Universe Pharmaceuticals INC (UPC)
4.691
+0.026 (0.55%)
Inactive · Last trade price on Sep 23, 2026
UPC Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 17.74 | 17.86 | 23.02 | 32.31 | 40.14 | 47.98 | |
Revenue Growth | -8.04% | -22.44% | -28.74% | -19.52% | -16.34% | 56.27% |
Cost of Revenue | 11.26 | 11.56 | 16.95 | 21.99 | 18.25 | 22.66 |
Gross Profit | 6.48 | 6.3 | 6.07 | 10.32 | 21.89 | 25.33 |
Selling, General & Admin | 7.9 | 8.55 | 11.06 | 9.33 | 21.27 | 6.17 |
Research & Development | 0.67 | 0.67 | 3.03 | 4.86 | 7.64 | 5.47 |
Other Operating Expenses | - | - | 0 | 0.1 | - | 0.1 |
Operating Expenses | 8.57 | 9.22 | 14.09 | 14.28 | 28.91 | 11.74 |
Operating Income | -2.09 | -2.92 | -8.02 | -3.97 | -7.02 | 13.59 |
Interest Expense | -0.29 | -0.29 | -0.3 | -0.19 | -0.2 | -0.15 |
Interest & Investment Income | 0.06 | 0.06 | 0.03 | 0.03 | 0.04 | 0.29 |
Earnings From Equity Investments | 0.07 | 0.07 | 0.03 | 0.03 | 0.04 | 0.03 |
Other Non Operating Income (Expenses) | 0.31 | -0.59 | 0.15 | -0.24 | 0.05 | -0.08 |
EBT Excluding Unusual Items | -1.94 | -3.67 | -8.12 | -4.33 | -7.09 | 13.68 |
Gain (Loss) on Sale of Assets | -0 | -0 | -0 | -0 | -0 | -0 |
Pretax Income | -1.94 | -3.67 | -8.12 | -4.33 | -7.09 | 13.68 |
Income Tax Expense | - | - | 0.61 | 2.25 | 0.82 | 2.36 |
Net Income | -1.94 | -3.67 | -8.73 | -6.58 | -7.91 | 11.32 |
Net Income to Common | -1.94 | -3.67 | -8.73 | -6.58 | -7.91 | 11.32 |
Net Income Growth | - | - | - | - | - | 49.77% |
Shares Outstanding (Basic) | 1 | 0 | 0 | - | - | - |
Shares Outstanding (Diluted) | 1 | 0 | 0 | - | - | - |
Shares Change | 205.01% | 3174.93% | - | - | - | - |
EPS (Basic) | -3.45 | -8.06 | -626.96 | - | - | - |
EPS (Diluted) | -3.45 | -8.06 | -626.96 | - | - | - |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -12.39 | -5.32 | -9.75 | 1.07 | -1.4 | -15.59 |
Free Cash Flow Per Share | -21.99 | -11.67 | -700.61 | - | - | - |
Gross Margin | 36.52% | 35.28% | 26.37% | 31.93% | 54.53% | 52.78% |
Operating Margin | -11.78% | -16.33% | -34.83% | -12.28% | -17.49% | 28.32% |
Profit Margin | -10.95% | -20.56% | -37.90% | -20.37% | -19.70% | 23.59% |
Free Cash Flow Margin | -69.85% | -29.78% | -42.36% | 3.32% | -3.48% | -32.48% |
EBITDA | -1.61 | -2.4 | -7.53 | -3.46 | -6.49 | 14.04 |
EBITDA Margin | -9.08% | -13.43% | -32.72% | -10.70% | -16.16% | 29.25% |
D&A For EBITDA | 0.48 | 0.52 | 0.49 | 0.51 | 0.53 | 0.45 |
EBIT | -2.09 | -2.92 | -8.02 | -3.97 | -7.02 | 13.59 |
EBIT Margin | -11.78% | -16.33% | -34.83% | -12.28% | -17.49% | 28.32% |
Effective Tax Rate | - | - | - | - | - | 17.24% |
Advertising Expenses | - | 2.57 | 5.27 | 4.76 | - | 1.33 |